Mobile App

Google Play Apple Store
Case-based Treatment Strategies in Patients with Chronic Immune Thrombocytopenia
Certified CME/CNE Activity
Treatment choices for chronic immune thrombocytopenia (ITP) are complicated by the heterogeneity of the disease and the inability not only to diagnose it but also to objectively predict patient responses to treatment and outcomes. With lack of head-to-head clinical trial comparisons to guide therapeutic options and sequencing of treatment strategies, as well as the development of emerging agents, expert opinion is critical in guiding clinical decision-making. Furthermore, ITP in the elderly and pregnant patient poses considerable challenges, so specific individualized management strategies ideally should be considered to optimize outcomes.

Using patient case studies, James Bussel, MD and Hanny Al-Samkari, MD discuss real-life management of patients with chronic ITP.
Review one or all activities of interest. Claim AMA or ANCC credit/contact hour(s) after completion of the post-test / evaluation.




James Bussel, MD James Bussel, MD
Professor Emeritus
Hematology-Oncology
Weill Cornell Medicine New York, NY  
Hanny Al-Samkari, MD Hanny Al-Samkari, MD
Hematologist and Clinical Investigator
Massachusetts General Hospital
Instructor of Medicine
Harvard Medical School

20

Supported by an independent educational grant from Dova Pharmaceuticals


Launch Date: December 2, 2020

Release Date: November 10, 2020

Expiration Date: October 31, 2021

October 31, 2021
Mini Module
6909
TalkingITP_EBlastBanner(1150).jpg
Hematology-Oncology